XCancer Omaha / Urology Cancer Center — Omaha, Nebraska

XCancer Omaha / Urology Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

XCancer Omaha / Urology Cancer Center has participated in 9 clinical trials with 7 currently active.

Therapeutic areas: Metastasis From Malignant Tumor of Prostate, Prostate Cancer, Pancreatic Ductal Adenocarcinoma (PDAC).

Sponsors: Curium US LLC, Brigham and Women's Hospital, 3B Pharmaceuticals GmbH.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for XCancer Omaha / Urology Cancer Center?

XCancer Omaha / Urology Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has XCancer Omaha / Urology Cancer Center conducted?

XCancer Omaha / Urology Cancer Center has 9 clinical trials on record, with 7 currently active. Their work covers Metastasis From Malignant Tumor of Prostate, Prostate Cancer, Pancreatic Ductal Adenocarcinoma (PDAC).

Is XCancer Omaha / Urology Cancer Center accredited by Crixeo Health?

Yes — XCancer Omaha / Urology Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about XCancer Omaha / Urology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.